Stručni radovi u 1998. godini

Drulović J, Mostarica-Stojković M, Lević Z, Mesaroš Š, Stojsavljević N, Popadić D, Pravica V. Serum interleukin-12 levels in patients with multiple sclerosis. Neurosci Lett 1998;251:129-132.
Drulović J, Dožić S, Lević Z, Stojsavljević N, Trikić R, Cvetković D, Apostolski S. Unusual association of multiple sclerosis and tomaculous neuropathy. J Neurol Sci 1998;157:217-222.
Apostolski S, Marinković Z, Nikolić A, Blagojević D, Spasić M.B, Michelson A.M: Gluthation peroxidase im amyotrophic lateral sclerosis-the effect of seenium supplementation. J.Environ.Pathol.Toxicol. Oncol.17,325-329,1998.
Šternić N, Kacar A, Stojanović M, Kostić VS. The therapeutic effect of moclobemide, a reversible monoaminooxidase A inhibitor, in Parkinson¢s disease. Clinical Neuropharmacology 1998; 21:93-96.
Svetel M, Šternić N, Kostić VS, Przedborski S. Antiparkinsonian effects of adenosine  antagonist in de novo and advanced Parkinsons disease patients. Ann Neurol 1998; 44: 501
Filipović S, Šternić N, Svetel M, Lećić D, Kostić VS. Depression in Parkinson¢s disease: an EEG frequency analysis study. Parkinsonism and Related Disorders 1998; 4:171-178.
Svetel M,Šternić N,Kostić VS, Przedborski S. Antiparkinsonian effects of adenosine antagonist in de novo and advanced Parkinsons disease patients. Ann Neurol 1998;44: 501.
Šternić N, Kačar A, Stojanović M, Kostić VS. The therapeutic effect of moclobemide, a reversible monoaminooxidase A inhibitor, in Parkinson¢s disease. Clin Neuropharmacol 1998; 21:93-96.
Popović M, Popović N, Bokonjić D, Dobrić S, Ugrešić N, Kostić VS. Effect of acute physostigmine and verapamil treatment on aggressive and depressive behavior in rats with lesioned nucleus basalis magnocellularis. Neurosci Res Comm 1998; 23:13-21.
Kostić VS, Stefanova E, Svetel M, Kozić D. A variant of the Kleine-Levin syndrome following head trauma. Beh Neurol 1998; 11:105-108.
Filipović S, Šternić N, Svetel M, Lećić D, Kostić VS. Depression in Parkinson¢s disease: an EEG frequency analysis study. Parkinsonism and Related Disorders 1998; 4:171-178.
Lavedan C, Buchhotz S, Auburger G, Albin RL, Athanassiadou A, Blancato J, Burguera JA, Ferrell RE, Kostić VS, Leroy E, Leube B, Mota-Vieira L, Papapetropoulos T, Pericak-Vance MA, Pincus J, Scott WK, Ulm G, Vasconelos J, Vilchez JJ, Nisbaum RL, Polymeropoulos MH. Absence of mutation in the beta- and gamma.synuclein genes in familial autosomal dominant Parkinson¢s disease. DNA Res 1998; 5:401-402.
Svetel M, Šternić N, Vojvodić N, Filipović S, Stanković P, Kostić VS. Spazmodična disfonija: između neurologa, psihijatra i otorinolaringologa. Acta Otorhinolaryngologica Serbica 1998; 2:133-137.
Svetel M, Šternić N, Kostić VS. Centralna inervacija larinksa. Acta Otorhinolaryngologica Serbica 1998; 3:569-571.
Svetel M, Šternić N, Kostić VS. Neurološke bolesti larinksa. Acta Otorhinolaryngologica Serbica 1998; 3:591-597.
Vojvodić N, Čuljković B, Romac S, Stojković O, Šternić N, Sokić D, Kostić VS. Značaj povećanja broja trinukleotidnih ponovaka za klinička ispoljavanja Hantingtonove horeje. Srpski Arhiv 1998; 126:77-82.
Šternić N, Svetel M, Filipović S, Kostić VS, Jovičić A, Kušić D, Žikić M, Vojinović D, Pantović M, Trajković V, Karalejić D, Petrović N, Dedić M, Vujisić S. Noćni problemi u Parkinsonovoj bolesti: terapijske mogućnosti HBS (hidrodinamski balansirani sistem) preparata levodope sa benzerazidom. Klinička i eksperimentalna neurologija 1998; 3:275-282.
Popović N, Popović M, Kostić VS. Alzheimerova bolest: mehanizmi inflamatorne reakcije i antiinflamatorna terapija. Klinička i eksperimentalna neurologija 1998; 3:283-298.
Šternić N, Radak Đ, Kostić VS. Indikacije za urgentnu endarterektomiju. Klinička i eksperimentalna neurologija 1998; 3:305-311.
Keckarević D, Stojković O, Čuljković B, Kostić VS, Rakić Lj, Romac S. Molekularno biološki i klinički aspekti Fridrajhove ataksije. Klinička i eksperimentalna neurologija 1998; 3:312-319.
S. Medić I V. Rakočević-Stojanović: Značaj merozina I sarkoglikana u pojavi nekih oblika mišićne distrofije. Srpski Arhiv, 1998:126;34-39.